Suppr超能文献

危重症系统性风湿病患者的一年预后:一项多中心队列研究。

One-Year Outcome of Critically Ill Patients With Systemic Rheumatic Disease: A Multicenter Cohort Study.

机构信息

Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier, France; PhyMedExp, INSERM, CNRS, Montpellier, France.

Department of Internal Medicine 2, E3M Institute, Paris, France; Medical Intensive Care Unit, Institute of Cardiology, La Pitie-Salpetriere Hospital, University of Paris 6, Paris, France.

出版信息

Chest. 2020 Sep;158(3):1017-1026. doi: 10.1016/j.chest.2020.03.050. Epub 2020 Apr 11.

Abstract

BACKGROUND

Critically ill patients with systemic rheumatic disease (SRD) have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality rates and, most importantly, long-term outcomes are scarce.

RESEARCH QUESTION

The aim of this study was to assess short and long-term outcome of patients with SRD who were admitted to the ICU.

STUDY DESIGN AND METHODS

All records of patients with SRD who were admitted to ICU between 2006 and 2016 were reviewed. In-hospital and one-year mortality rates were assessed, and predictive factors of death were identified.

RESULTS

A total of 525 patients with SRD were included. Causes of admission were most frequently shock (40.8%) and acute respiratory failure (31.8%). Main diagnoses were infection (39%) and SRD flare-up (35%). In-hospital and one-year mortality rates were 30.5% and 37.7%, respectively. Predictive factors that were associated with in-hospital and one-year mortalities were, respectively, age, prior corticosteroid therapy, simplified acute physiology score II ≥50, need for invasive mechanical ventilation, or need for renal replacement therapy. Knaus scale C or D and prior conventional disease modifying antirheumatic drug therapy was associated independently with death one-year after ICU admission.

INTERPRETATION

Critically ill patients with SRD had a fair outcome after an ICU stay. Increased age, prior corticosteroid therapy, and severity of critical illness were associated significantly with short- and long-term mortality rates. The one-year mortality rate was also associated with prior health status and conventional disease modifying antirheumatic drug therapy.

摘要

背景

近年来,患有系统性风湿病(SRD)的危重症患者通过更好地提供风湿病和重症护理而受益。最近有关住院死亡率的数据很全面,最重要的是长期预后数据却很缺乏。

研究问题

本研究旨在评估入住 ICU 的 SRD 患者的短期和长期预后。

研究设计和方法

回顾了 2006 年至 2016 年期间入住 ICU 的 SRD 患者的所有记录。评估了住院和 1 年死亡率,并确定了死亡的预测因素。

结果

共纳入了 525 例 SRD 患者。导致入院的主要原因是休克(40.8%)和急性呼吸衰竭(31.8%)。主要诊断为感染(39%)和 SRD 发作(35%)。住院和 1 年死亡率分别为 30.5%和 37.7%。与住院和 1 年死亡率相关的预测因素分别为年龄、皮质类固醇治疗史、简化急性生理学评分 II≥50、需要有创机械通气或需要肾脏替代治疗。Knaus 分级 C 或 D 和常规疾病修饰抗风湿药物治疗史与入住 ICU 1 年后的死亡独立相关。

解释

入住 ICU 的 SRD 患者预后尚可。年龄增加、皮质类固醇治疗史和危重症严重程度与短期和长期死亡率显著相关。1 年死亡率还与既往健康状况和常规疾病修饰抗风湿药物治疗相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验